D-1376-2015 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-1376-2015 was initiated by Dr. Reddy's Laboratories, Inc. on Aug 13, 2015 and is designated Class III. Reason for recall: Subpotent Drug: Subpotent atorvastatin. The recall status is terminated (terminated Dec 15, 2016). Affected quantity: a) 14,640 and b) 624 Bottles.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2015
Initiation Date
Aug 13, 2015
Termination Date
Dec 15, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 14,640 and b) 624 Bottles

Product description

Amlodipine besylate and Atorvastatin calcium Tablets, 5 mg/20 mg, Packaged in a) 30 Count Bottles (NDC: 43598-319-30) and b) 90 Count Bottles (NDC: 43598-319-90), Rx Only. Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 India.

Reason for recall

Subpotent Drug: Subpotent atorvastatin.

Distribution pattern

U.S. Nationwide

Code information

a) Lot #: C403577, Expiry: 10/2015; b) Lot #: C403577, Expiry: 10/2015.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1376-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1376-2015. Report a data issue: hello@regdatalab.com.